Information for Health Care Professionals
Health care providers play a critical role in sharing information with their patients about COVID-19 and immunization. Additional information on vaccine development, authorized vaccines and vaccine is available through the federal government’s COVID-19 Vaccination Tool Kit for Health Care Providers.
Selected health care providers are among Manitoba’s first priority group for immunization. For more information about eligibility criteria and the current clinic, visit Immunization Clinics.
If you are interested in joining Team Manitoba to work at an immunization clinic, learn more about available positions.
Manitoba COVID-19 Vaccine: Clinical Practice Guidelines for Immunizers and Health Care Providers (pdf, November 23, 2021)
More information:
November 2021
COVID-19 Vaccine: Approval/Guidance for Children aged five to ≤ 11 years (pdf, November 23, 2021)
COVID-19 Vaccine Update: Pharmacists to Start Administering COVID-19 and Influenza Vaccines to Those Five Years of Age and Older (pdf, November 16, 2021)
COVID-19 Vaccine Update: Expanded Third/ Booster Dose 6 Months After Dose 2 Guidance (pdf, November 10, 2021)
COVID-19 Vaccine: Third/Booster Dose Update (pdf, November 5, 2021)
COVID-19 Vaccine RE: Important Program Updates (pdf, November 3, 2021)
Moderna/Spikevax - Shelf life extension for US Labeled 14 dose vials (pdf, October 29, 2021)
COVID-19 Vaccine: Booster/Third Dose Guidance and Expansion to Include Residents of Congregate Elderly Person Housing Sites (pdf, October 27, 2021)
COVID-19 Vaccine Medical Exemption Program (pdf, October 6, 2021)
COVID-19 Vaccine: Expansion of Third Doses to Health Care Personnel and to People who received a Viral Vector Vaccine Series (pdf, October 5, 2021)
Manitoba Adopting National Advisory Committee on Immunization (NACI) Guidance (pdf, October 1, 2021)
COVID-19 Vaccine Guidance for Personal Care Homes: Recommended Interval between Second and Third Doses of COVID-19 Vaccine & Update on COVID-19/Flu Vaccine Sequence of Administration (pdf, September 23, 2021)
COVID-19 Vaccine: Expansion of Third Doses to Personal Care Homes (pdf, September 20, 2021)
COVID-19 Vaccine: Additional Information on Third Doses (pdf, September 17, 2021)
COVID-19 Vaccine: Additional mRNA Vaccine Dose for Certain Populations and Medical Exemption Program (pdf, September 15, 2021)
Reporting COVID-19 and School Vaccine Doses Administered to Clients without a PHIN (pdf, September 2021)
Pfizer - Shelf life extension for identified lots in Ultra Low Temperature Storage (pdf, August 30, 2021)
COVID-19 Vaccine: Recommendations for Immunizing Adolescents (pdf, August 2021)
COVID-19 Vaccine: Updated Age Eligibility Criteria for Children (pdf, August 2021)
COVID-19 Vaccine: Allergy Assessment and Referral (pdf, June 2021)
IMPORTANT NOTICE: Effective immediately, pause use of AstraZeneca / COVISHIELD in People aged < 55 years (pdf, March 29, 2021)
First Nations Identification for the Purpose of Booking AstraZeneca/ Covishield Vaccination (pdf, March 29, 2021)
Manitoba COVID-19 Vaccine: Updated AstraZeneca and COVISHIELD Product Monographs and Health Product Risk Communication (pdf, March 25, 2021)
Health Product Risk Communication: Important Safety Information on AstraZeneca and COVISHIELD Vaccines (pdf, March 24, 2021)
COVID-19 Vaccine: New/Updated Communications Products including Clinical Practice Guidelines and Consent Form (pdf, March 15, 2021)
COVID-19 Vaccine: Guidance for Immunizers to Select the Reason for Immunization (pdf, March 2, 2021)
Memo to Health Care Providers on Enhanced Consent (pdf, January 25, 2021)
Pfizer BioNTech - Information for health care providers (manufacturer site)
CanVax: COVID-19 Vaccine Questions and Answers for Healthcare Providers
Memo to Health Care Providers (pdf, December 15, 2020)
